The nurse is caring for a client receiving a prescription for sucralfate to treat a peptic ulcer. Which instruction should the nurse provide during discharge education?

A. Initiate cardiopulmonary resuscitation (CPR):
While initiating CPR is critical for clients experiencing cardiac or respiratory arrest, it is not the immediate action in this scenario. The client’s respiratory depression is most likely related to opioid toxicity, which can sometimes be reversed with naloxone. Before resorting to CPR, the priority is to address the potential cause of the respiratory depression.
B. Prepare to assist with chest tube insertion:
Chest tube insertion is typically indicated for conditions such as pneumothorax or pleural effusion, not for opioid-induced respiratory depression. In this case, the client’s symptoms are likely related to the effects of opioids and naloxone administration, not a need for chest tube insertion
C. Determine Glasgow Coma Scale score:
While assessing the Glasgow Coma Scale (GCS) score is important for evaluating the client's level of consciousness and neurological status, it does not address the immediate need to counteract opioid toxicity. The priority is to manage the respiratory depression that could be life-threatening.
D. Administer a second dose of naloxone:
Administering a second dose of naloxone is the most appropriate action in this scenario. Naloxone is used to reverse opioid-induced respiratory depression, and if the initial dose did not fully counteract the effects of the opioid, a second dose may be necessary. The client's severe respiratory depression and low oxygen saturation indicate that opioid effects may still be present, warranting additional naloxone administration.

A. High-density lipoprotein (HDL): While HDL levels are important for assessing cardiovascular risk, atorvastatin primarily targets the reduction of low-density lipoprotein (LDL) cholesterol. An increase in HDL is generally beneficial, but it is not the primary measure of atorvastatin's effectiveness.
B. Prothrombin time (PT): PT measures blood clotting ability and is not directly related to the effectiveness of atorvastatin. Atorvastatin’s role is to manage cholesterol levels, not to influence coagulation directly.
C. Creatine phosphokinase (CK): CK levels can be monitored to assess muscle damage or myopathy, a potential side effect of atorvastatin. However, changes in CK are not a direct measure of the medication’s effectiveness in lowering cholesterol.
D. Low-density lipoprotein (LDL): This is the most appropriate indicator of atorvastatin's effectiveness. Atorvastatin is a statin medication used to lower LDL cholesterol levels, which is a primary goal in managing and reducing the risk of coronary artery disease. A decrease in LDL cholesterol levels reflects that the medication is working as intended.